$4550
[Research Report] The cardiac microcatheter market is projected to reach US$ 487.20 million by 2028 from US$ 332.97 million in 2022. It is expected to register a CAGR of 6.8% from 2023 to 2028.
Analyst Perspective
The rising prevalence of cardiovascular diseases and growing use of percutaneous coronary intervention drive the cardiac microcatheter market growth. The rising number of patients suffering from chronic conditions and increasing activities in research and development are the key factors propelling the market for cardiac microcatheter. Furthermore, the cardiac microcatheter market key players are focusing on strategic initiatives by launching new products to expand their geographic reach and enhance capacities to cater to a large customer base. For instance, in May 2023, Acotec Scientific Holdings Ltd. received Chinese marketing approval for its microcatheter Vericor-14 to assist in percutaneous coronary interventions and percutaneous peripheral interventions, taking a step ahead in a competitive market that is poised to grow eightfold by the end of the decade.
Market Overview
Cardiac microcatheters are specialized devices used in interventional cardiology procedures to access and treat various cardiovascular conditions. These microcatheter are designed to navigate the complex anatomy of the heart and its blood vessels with precision and control. Cardiac microcatheters are used in a variety of procedures, including angioplasty, angiography, atherectomy, and thrombectomy, as well in the placement of stents or other devices. They provide access to coronary arteries and can deliver therapeutic agents or devices to treat blockages, narrowing, or other abnormalities.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cardiac Microcatheter Market: Strategic Insights
Market Size Value in US$ 332.97 million in 2022 Market Size Value by US$ 487.20 million by 2028 Growth rate CAGR of 6.8% from 2023 to 2028 Forecast Period 2023-2028 Base Year 2023
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cardiac Microcatheter Market: Strategic Insights

Market Size Value in | US$ 332.97 million in 2022 |
Market Size Value by | US$ 487.20 million by 2028 |
Growth rate | CAGR of 6.8% from 2023 to 2028 |
Forecast Period | 2023-2028 |
Base Year | 2023 |

Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Market Driver
Increasing Prevalence of Cardiovascular Diseases Drives Global Cardiac Microcatheter Market
According to the World Health Organization (WHO), cardiovascular diseases are the most prominent cause of morbidity and mortality worldwide. cardiovascular diseases include cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Major lifestyle factors causing cardiovascular diseases and related difficulties are tobacco consumption, unhealthy diet, and physical inactivity, among others. The other risk factors related to cardiovascular diseases are high blood pressure, diabetes, and elevated cholesterol levels. Heart attacks and strokes are mainly caused by fatty deposits that block blood vessels, disrupting blood flow to the heart or brain. According to a report from American Heart Association, in 2020, ~19 million deaths were attributed to cardiovascular diseases globally, which amounted to an increase of 18.7% from 2010. Ischemic heart disease was the most common cause of cardiovascular mortality, claiming more than 9.4 million lives and 185 million disability-adjusted life-years in 2020, while ischemic stroke, intracerebral hemorrhage, hypertensive heart disease, and rheumatic heart disease rounded out to be the top 5 leading causes.
According to American Heart Association Inc., the cardiovascular diseases -related deaths recorded in 2020 increased to 928,741 from 874,613 in 2019. Between 2018 and 2019, direct and indirect costs of total cardiovascular diseases were US$ 407.3 billion (US$ 251.4 billion in direct costs and US$ 155.9 billion in lost productivity/mortality). In 2020, coronary heart disease was the leading cause (41.2%) of deaths attributable to cardiovascular diseases in the US, followed by stroke (17.3%), high blood pressure (12.9%), heart failure (9.2%), diseases of the arteries (2.6%), and other cardiovascular diseases (16.8%). Also, the World Heart Federation predicts more than 23 million cardiovascular diseases -related deaths per year by 2030.
According to a study “Cardiovascular Diseases in Central and Eastern Europe,” published in 2020 by European Society of Cardiology, cardiovascular diseases are the leading cause of death in Europe, accounting for 45% of all deaths. Cardiovascular risk factors are highly prevalent in Central and Western Europe, owing to smoking habits and heavy alcohol consumption rates, especially among men. More than 4 million Europeans die yearly from cardiovascular diseases, mainly due to coronary artery disease and stroke. The Middle East too has a high prevalence rate of cardiovascular diseases, which has surged the need for various interventions such as health education, lifestyle counseling, screening, and treatment in this region. According to the World Heart Federation, cardiovascular disease is the primary cause of death in the Middle East & North Africa, accounting for more than a third of all deaths or 1.4 million people annually. Furthermore, over the past 30 years, cardiovascular diseases deaths have increased by 48%, accounting for 40% and 10% of deaths in Oman and Somalia, respectively. In 2021, age-standardized cardiovascular diseases mortality rates in the Middle East and North Africa ranged from 134.2 to 600.2 per 100,000 people. Therefore, the high prevalence of cardiovascular diseases is boosting the cardiac microcatheter market.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Segmental Analysis
Based on indication, the cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held a larger market share in 2022 and is anticipated to register a higher CAGR of 6.9% during the forecast period. The market position of this segment is due to the precision and control the coronary microcatheter offer. Microcatherthers are extremely thin and flexible, enabling cardiologists to navigate through the intricate network of coronary arteries with precision and control. They can reach even the narrowest and most tortuous vessels, allowing for accurate diagnosis and targeted treatment.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Regional Analysis
North America is the dominating region in the cardiac microcatheter market. The North America cardiac microcatheter market was valued at US$ 127.55 million in 2022 and is projected to reach US$ 188.10 million by 2028; it is expected to register a CAGR of 6.9% during the forecast period. The North-America cardiac microcatheter market is segmented into the US, Canada, and Mexico. The regional market growth is attributed to factors such as increasing incidence of heart diseases, including cardiovascular diseases, stroke, and others, coupled with well-developed healthcare infrastructure. The high preference for minimally invasive procedures among a large patient population and healthcare professionals to treat cardiac disorders is expected to promote the cardiac microcatheter market growth during the forecast period.
Key Player Analysis
Boston Scientific Corp, Teleflex Inc, Medtronic Plc, OrbusNeich Medical Group Holdings Ltd, Asahi Intecc USA Inc, Merit Medical Systems Inc, Nipro Corp, Terumo Corp, Tokai Medical Products Inc, and Integer Holdings Corp. are among the major players operating in the cardiac microcatheter market. Among these players, Medtronic Plc and Boston Scientific Corp are the top two players owing to the diversified product portfolio they offer.
Recent Developments
Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the cardiac microcatheter market. A few recent key market developments are listed below:
- In 2019, Navitian, a new coronary microcatheter from iVascular, received the CE mark approval. The device was approved to facilitate, guide, and support a guidewire while accessing the coronary system, exchanging guidewires, and injecting radiopaque contrast media or saline solutions.
- In 2020, Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist Navvus II Rapid Exchange fractional flow reserve (FFR) microcatheter, the second-generation microcatheter for use with its Acist RXi Rapid Exchange FFR System. FFR measurements assess arterial lesion severity and the intervention strategies in diagnosing and treating coronary artery disease.
- In 2021, Baylis Medical unveiled the first clinical case of the JLL 2-French electrophysiology microcatheter in Europe. The launch enables physicians to reach previously inaccessible areas of the heart for procedure mapping, thereby introducing the smallest diagnostic catheter available in the European market. The 2F microcatheter also allows mapping and pacing in smaller anatomy, such as the Vein of Marshall.
- In 2023, Al Qassimi Hospital in the UAE collaborated with Philips in order to allow access to Ultra-Low Contrast Percutaneous Coronary Intervention (ULC-PCI) to more patients in the Middle East, Turkey, and Africa. The new ULC-PCI Interventional Cardiology course at Al Qassimi Hospital is part of a global education program by Philips to share knowledge regarding the technology that can offer low-contrast, minimally invasive treatment for coronary artery disease, thereby spreading awareness among patients.

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Indication, and End User

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The CAGR value of the cardiac microcatheter during the forecasted period of 2023-2028 is 6.8%.
Coronary segment held the largest share of the market in the cardiac microcatheter and held the largest market share in 2022.
Key factors that are driving the growth of this market are increasing prevalence of cardiovascular diseases and the growing use of percutaneous coronary intervention (PCI) for treating chronic total occlusions (CTO).
Medtronic Plc and Boston Scientific Corporation. are the top two companies that hold huge market shares in the cardiac microcatheter.
Microcatheter is defined as a small diameter catheter that is used in minimally invasive procedures for delivering devices. Its small build makes it ideal for navigating complex vasculature within the human body. It is used for guidewire support, exchanges, to access distal anatomy, cross lesions, deliver therapeutic embolic, inject contrast media, and perform other procedures in complex endovascular procedures. Microcatheters are also commonly used in percutaneous coronary intervention (PCI). The growth is attributable to the increasing prevalence of cardiovascular diseases and the growing use of percutaneous coronary intervention (PCI) for treating chronic total occlusions (CTO).
The hospitals segment dominated the cardiac microcatheter and held the largest market share in 2022.
The Cardiac microcatheter majorly consists of the players such as Boston Scientific Corp, Teleflex Inc, Medtronic Plc, OrbusNeich Medical Group Holdings Ltd, Asahi Intecc USA Inc, Merit Medical Systems Inc, Nipro Corp, Terumo Corp, Tokai Medical Products Inc, Integer Holdings Corp, and among others. .
The List of Companies - Cardiac Microcatheter Market
- Boston Scientific Corp
- Teleflex Inc
- Medtronic Plc
- OrbusNeich Medical Group Holdings Ltd
- Asahi Intecc USA Inc
- Merit Medical Systems Inc
- Nipro Corp
- Terumo Corp
- Tokai Medical Products Inc
- Integer Holdings Corp.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Cardiac Microcatheter Market

Jun 2023
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Jun 2023
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography

Jun 2023
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

Jun 2023
Coagulation Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von Willebrand's Disease, and Others), Type [Clinical Laboratory Analyzers (Controls & Calibrators, Assays & Reagents, Instruments/Systems, Coagulation Factors, and Others) and Point-of-Care Testing Analyzers], Offering [Diagnosis (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimmer Testing, Platelets Function Testing, and Others) and Treatment (Anti-Fibrinolytic Drugs, Birth Control Pills, Desmopressin & Immunosuppressive Medicines, Vitamin K Supplements, Blood Thinners, Thrombin Inhibitors or Thrombolytics, Replacement Therapy, Catheter-Assisted Thrombus Removal, and Others)], Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), End User (Clinical Laboratories, Hospitals, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

Jun 2023
Pharmacy Automation Systems Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Automation Medication Dispensing Systems (Product Type and Operation), Automated Packaging and Labelling Systems, Automated Table-Top Counters, Automated Storage and Retrieval Systems, and Other Types], End User (Hospital Pharmacy, Retail Pharmacy, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Jun 2023
DNA Extraction, Isolation, and Purification Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Kits, Instruments, and Reagents), Method (Chemical Method and Physical Method), Sample Type (Blood, Body Fluids, and Others), Source (Genomic DNA and Microbial DNA), Application [PCR Test, Next Generation Sequencing (NGS), Microarray, and Others], End User (Hospitals, Diagnostic Centers and Research Laboratories, Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa and South and Central America)

Jun 2023
Molecular Diagnostic for Infectious Diseases Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Point-of-Care Testing and Laboratory Testing), End User [Point-of-Care Testing (Human Testing and Vet Testing) and Laboratory Testing (Human Testing and Vet Testing)], Application [Point-of-Care Testing (Detection of Single Pathogen, Detection of Two or More Pathogens, Evaluation of Emerging Novel Infections, Surveillance and Early Detection of Biothreat Agents and Diseases-Related Biomarker, and Antimicrobial Resistance Profiling) and Laboratory Testing (Patient stratification, Drug Regimen Selection, Toxicity Avoidance, Therapeutic Monitoring, and Detection of Predisposition to Disease)], Disease Type [Point-of-Care Testing (Sepsis, Prosthetic Joint Infection, Endocarditis, STDs, Mononucleosis, Group A Streptococcus, and Others) and Laboratory Testing (Sepsis, Prosthetic Joint infection, Endocarditis, STDs, Chlamydia, Gastrointestinal Infection, Tuberculosis, H1N1 Virus, and Others)], Infection Type [Point-of-Care Testing (Bacteria, Viral, Fungi, and Others) and Laboratory Testing (Bacteria, Viral, Fungi, and Others)], and Geography (North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa)

Jun 2023
Bovine Diagnostics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products), Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Types], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography